Category: biotechnology
For Immediate Release: Date: 02/24/10
Contacts:
Massachusetts Life Sciences Center
Angus G. McQuilken, Vice President for Communications
Phone: 617-921-7749 Email: amcquilken@masslifesciences.com
WPI/Gateway Park
Michael Cohen
Phone: 508-868-4778 Email: mcohen@wpi.edu
Grant leverages $25 million private investment for development of a new facility that will create jobs, house young companies and provide training programs in the life sciences
Waltham, MA— The Massachusetts Life Sciences Center Board of Directors today awarded a $6.6 million grant to Worcester Polytechnic Institute (WPI) to support the next phase of life sciences related development at Gateway Park in Worcester. The grant leverages $25 million in private investment for the development of a new 80,000-square-foot life sciences facility anticipated to create 120 construction jobs and 142 new permanent jobs at completion.
The grant supports the development of WPI’s Biomanufacturing Education and Training Center (BETC); a new incubator for Massachusetts Biomedical Initiatives (MBI); and expanded academic and research space, including new facilities for the Massachusetts Academy of Math and Science. The BETC is planning a 10,000-square-foot facility that will provide hands-on biomanufacturing training to support industry workforce development. MBI is planning to expand its incubator resources by developing a new wet-lab core facility to help more companies launch, grow and provide jobs. MBI currently operates three life sciences incubators in Central Massachusetts (one of which is located in the first Gateway Park building) and has graduated 30 companies, creating 265 new jobs since 2000.
 |
|
Grantwriting 101
including SBIR and STTRs
|
|
qed@qb3 - UCB
Friday, February 5, 2010
12:00 to 1:00 pm
Stanley Hall Room 621
|
SBIR/STTR grants can provide the critical funding necessary to launch your company. But success requires mastering the tricks of the SBIR/STTR program, some of which have frustrated excellent groups. From where to register to uploading your proposal, we'll cover the ins and outs of preparing grants for the NIH. This seminar is aimed at new and experienced grantwriters, from academia and industry. Even veteran grantwriters will benefit from a review of the new formats required as of January 2010.
Shauna Farr-Jones has a 10-year record of writing successful government grant and contract proposals on diverse life science topics, providing strategic input on both research and business plans. She has helped companies secure over $125 million in grant and contract funding from government and philanthropic agencies. Previously, she was at BioCentury Publications, where she analyzed the biotechnology industry. She was a postdoc in PharmChem at UCSF after a Ph.D. in Biochem from Tufts.
Amy F. Boggs is an independent consultant with more than 8 years experience in grant-writing. She also handles the preparation of technical reports, INDs and NDAs, technology assessment, strategic research planning, and competitive landscaping. Prior, Dr. Boggs worked at Microcide and at IntraBiotics, where she managed an interdisciplinary technology in-licensing team. Dr. Boggs is an inventor on three issued patents and has worked on IND-enabling projects. She completed a Ph.D. in PharmChem at UCSF under Dr. Agard.
Lunch provided, but space is limited so please reserve a seat at http://www.acteva.com/booking.cfm?bevaID=197134
The Chicago Technology Park exists as part of the larger Illinois Medical District to provide a home to the many businesses generated or attracted by the research and care provided through the District. The Research Center is the Technology Park’s business incubator where young companies and their cohort of partners may build businesses around innovation. The biotech incubator supports entrepreneurs with a network of consortia to fund and direct growth for success.
The new Biodesign Impact Accelerator is going to be opening up for its initial tenants soon at the Arizona State University (ASU) Biodesign Institute in Tempe, Arizona. This venture advances a new model for technology transfer in collaboration with regional initiatives to bring innovation to the global marketplace.
The new model for commercializing research at the Biodesign Institute includes Arizona Technology Enterprises (AzTE) and SkySong, the ASU Scottsdale Innovation Center. The Impact Accelerator will act like a venture fund to support incubated companies with the inclusion of ASU Technopolis and local partners to continue along Arizona’s Bio Roadmap for building a bioscience infrastructure of international significance.1
Massachusetts Lieutenant Governor Timothy Murray joins state and local officials for ribbon-cutting ceremony
Ben Franklin TechVentures is raising young, early stage companies and developing businesses in a community charged with entrepreneurship and the spirit of economic development. The incubator/ post incubator facility has the hard to come by wet lab space young biotechs need to develop fully in a region centrally located within reach of New York, Philadelphia and New Jersey. In addition to BFTP of Northeastern Pennsylvania, TechVentures is located within Lehigh University’s Mountain Top Campus alongside local incentives and support; and with an expansion in the works, this is an attractive location for any young start up.
The Nidus Center for Scientific Enterprise focuses on incubating plant biotechnology and life science businesses in St. Louis, Missouri. Until this summer the Nidus Center had occupied 40,000 square feet on the campus of Monsanto Company’s world headquarters. Recently, the Nidus Center moved to the Danforth Plant Science Center campus's Bio-Research and Development growth Park (BRDG-Park) freeing the previously held offices and lab space for Monsanto to operate.
Philadelphia, PA. November 1, 2009 /BUSINESS WIRE/--Integral Molecular, Inc. has been selected to receive a five year, $9.1 million contract from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health, to elucidate novel B cell epitopes on the surface of viral pathogens.
 |
|
Coming to Terms with your Term Sheet
Speakers: Thomas E. Duley, Attorney, Morgan Lewis
Sarita K. Jain, PhD, J&J Venture Investments
|
|
Thursday, November 5, 2009
12:00 to 1:00 pm
Byers Hall Room 212
|
First company that banks amniotic stem cells for families, researchers
MEDFORD, MA (Oct. 22) - Biocell Center, a European biotechnology company that is the only firm to harvest and preserve amniotic stem cells, announced today that it is expanding its tissue bank and research operations to serve families, medical centers and scientists in the United States.
